Close Menu

chlamydia

Life Tech's 7500 Fast Dx and 3500 Dx Series Genetic Analyzer approved in Japan; Roche files Cobas CT/NG test with FDA.

The platform will combine immiscible phase filtration sample prep with automated amplification and detection, and is expected to have initial applications in point-of-care HIV testing in remote and resource-poor areas of the world. The company also sees the platform being used for decentralized molecular testing in more developed countries.

As part of the deal, FIND will have rights to sell the HIV test, as well as Cepheid's Xpert chlamydia and gonorrhea tests, which will be sold at a discount to the public and the not-for-profit sector in some countries.

Gen-Probe just launched the Panther system in Europe with its initial menu focused on STD tests. The firm believes menu expansion will drive double-digit sales growth for years to come.

The platform will be based on isothermal amplification and its developers aim to cut the amount of time it takes to diagnose STDs to 15 minutes or less at the point of care.

Abbott's system can be used to detect a new strain of chlamydia initially detected in 2008.

At last week's Sample Prep 2010 meeting in Baltimore, Md., microfluidics, integration, and automation were oft-cited as future market drivers in the area of sample prep for virus, toxin, and pathogen detection.

Enigma struck the alliance with Tecan in anticipation of a fourth-quarter commercial launch of its miniaturized PCR instrument for point-of-care influenza diagnostic tests in Europe in partnership with GlaxoSmithKline.

Quidel said that Diagnostic Hybrids' fluorescent in vitro diagnostic assays would complement Quidel's point-of-care diagnostics for infectious disease and reproductive health.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.